Comparing the use of coronary revascularization in France and the United States: Divergent trends
Archives of Cardiovascular Diseases · 2026
DOI: 10.1016/j.acvd.2026.02.002 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Archives of Cardiovascular Diseases, 2026. Verfasst von Michael K Gusmano und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Health, Lehigh University, Bethlehem, PA 18015, United States. Hauptthemen laut MEDLINE: Coronary Artery Bypass, Percutaneous Coronary Intervention, Coronary Artery Disease, Practice Patterns, Physicians'. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Coronary revascularization is a key treatment for coronary artery disease (CAD). Over the past 15years, several randomized trials have shown that it failed to improve life expectancy in most patients with stable CAD. AIM: To compare trends in the use of coronary revascularization from 2012 to 2018 in France and the United States (US). METHODS: Administrative databases were used in both countries to identify patients ≥35years of age, hospitalized for CAD or congestive heart failure (CHF) undergoing coronary artery bypass graft (CABG) or percutaneous coronary intervention (PCI), as identified from the International Classification of Diseases coding system. Independent correlates of the use of coronary revascularization were also investigated. RESULTS: In France, from 2012 to 2018, coronary revascularization increased by 13.3% among patients aged 35-64years and by 24.6% among those aged ≥65years. In contrast, in the US, it decreased by 16.3% and 19.6%, respectively. These trends were mainly related to the use of PCI: +15.8% and +28.8% in France versus-17.6% and-20.4% in the US. These divergent trends could not be explained solely by changes in the number of hospitalizations for CAD/CHF. In both countries and for both periods, use of revascularization was independently related to age, number of medical diagnoses, sex and income. CONCLUSION: Divergent trends in the use of coronary revascularization were observed in France and the US that could not be explained by trends in the number of CAD/CHF hospitalizations, nor by differences in the correlates of its use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Health, Lehigh University, Bethlehem, PA 18015, United States.
- Wagner School of Public Service, New York University, New York, NY 10003, United States.
- R.N. Butler Columbia Aging Center, Columbia University, New York, NY 10032, United States.
- Biostatistics and Bioinformatics (DIM), University Hospital, 21000 Dijon, France; Bourgogne Franche-Comté University, 21000 Dijon, France.
- Department of Cardiology, Hôpital Saint Joseph, 75014 Paris, France. Electronic address: nicolas.danchin.pro@gmail.com.
- Biostatistics and Bioinformatics (DIM), University Hospital, 21000 Dijon, France; Bourgogne Franche-Comté University, 21000 Dijon, France; Inserm, CIC 1432, 21000 Dijon, France; Dijon University Hospital, Clinical Inves…
Zitieren
APA
Gusmano, M. K., Rodwin, V. G., Weisz, D., Cottenet, J., Danchin, N., & Quantin, C. (2026). Comparing the use of coronary revascularization in France and the United States: Divergent trends. Archives of Cardiovascular Diseases. https://doi.org/10.1016/j.acvd.2026.02.002
Vancouver
Gusmano MK, Rodwin VG, Weisz D, Cottenet J, Danchin N, Quantin C. Comparing the use of coronary revascularization in France and the United States: Divergent trends. Archives of Cardiovascular Diseases. 2026. doi:10.1016/j.acvd.2026.02.002
BibTeX
@article{Gusmano2026,
author = {Gusmano, Michael K and Rodwin, Victor G and Weisz, Daniel and Cottenet, Jonathan and Danchin, Nicolas and Quantin, Catherine},
title = {Comparing the use of coronary revascularization in France and the United States: Divergent trends},
journal = {Archives of Cardiovascular Diseases},
year = {2026},
doi = {10.1016/j.acvd.2026.02.002}
}
EUVIMED